Brexit: UK Gov’t Says Retaining The EMA Cannot Be A “Line In The Sand” Matter
Executive Summary
The European Medicines Agency is important to the UK but the government cannot say it will be a non-negotiable point in future talks regarding the country’s departure from the EU.
You may also be interested in...
Brexit: EMA Has A Visit A Week From Potential Hosts
At least half a dozen countries are interested in hosting the European Medicines Agency if Brexit means it has to leave London. But do they have what it would take?
UK MPs On Brexit: EMA And MHRA Are ‘Completely Intermingled’
Perhaps appealing to the wider European audience, UK legislators debating Brexit’s impact warn of damage to EU and as well as UK regulatory systems.
‘Standardized’ Comment From Brexit Minister Raises Hopes For Parallel EU/UK Drug Approval System
The way in which pharmaceuticals might be regulated in the UK after the country leaves the EU is a big unknown. As MPs get to have their say on the matter, the Pink Sheet tries to gauge government thinking.